Watkin Jones plc Progressive publishes new research

RNS Number : 2606P

Watkin Jones plc

21 May 2024

 

Guidance unchanged as investment rekindles Watkin Jones has maintained its FY24E guidance following today's results for the six months to 31 March, which showed operating profit more than doubling. The group continues to expect a heavy H2 weighting as it has focused on operational performance while the forward-funding market has remained largely on hold, pending further clarity on the direction of interest rates. Sentiment is now gradually improving, according to the group.

Click here for full analysis

 

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

 

Progressive helps you make informed investment decisions. FCA authorised and regulated, and with a 15-strong team of highly experienced analysts, we provide freely available institutional grade equity research and access to company management teams across every sector of the market.

 

www.progressive-research.com

 

Broad coverage		Analyst calibre
across 12 sectors
Business Services	Oil & Gas	15 analysts	with average	20 years
Financials	Property		experience of
Healthcare	Retail
Industrials	Technology	30+		techMARK
Investment Trusts	Telecoms		industry based	Extel
Mining	Utilities		awards	StarMine

 

 

For further information please contact:

 

[phone]

[e-mail]

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAABMRTMTMTMII